Vanda Pharmaceuticals Inc. Cash Flow Statement

1Y3Y5Y7Y10YAll
Download Data
Cash Flow Statement Dec2009 Dec2010 Dec2011 Dec2012 Dec2013 Dec2014 Dec2015 Dec2016 Dec2017 Dec2018 Dec2019 Dec2020 Dec2021 Dec2022 Dec2023 Dec2024
Operating Activities
Net Income -35.86M6.86M-9.10M-28.62M-21.05M20.19M-39.87M-18.01M-15.57M25.21M115.55M23.34M33.15M6.28M2.51M-18.90M
Depreciation and Depletion 0.43M0.53M0.58M0.94M1.23M1.43M1.40M1.40M1.40M1.22M0.92M0.90M
Share-based Compensation 11.23M4.98M5.50M5.05M5.40M5.88M7.96M8.54M10.46M11.67M13.46M13.36M15.37M16.28M14.04M12.43M
Deferred Taxes -1.82M1.82M-0.10M-87.77M6.19M6.75M1.13M-1.29M-6.48M
Gains from Sales and Divestitures 0.00M0.00M0.20M0.21M0.23M0.29M0.36M
Gains from Investment Securities 0.48M4.25M4.87M0.05M0.03M-0.48M-0.54M-0.59M-0.17M-1.78M-1.76M-1.73M-2.46M-3.42M-2.61M
Non-cash Items 5.23M2.02M1.51M21.26M28.52M7.50M32.45M24.42M
Cash from Operations 169.34M-10.90M-28.41M-44.92M-39.59M-81.55M12.45M-8.10M-1.98M29.99M45.95M51.77M64.21M31.98M12.80M-15.76M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles 0.98M1.50M1.50M1.50M1.50M2.25M12.97M10.93M1.75M2.22M3.10M1.48M-1.65M2.96M8.80M7.27M
Depreciation & Amortization (CF) 0.44M0.34M0.47M0.63M0.43M0.53M0.58M0.94M1.23M1.43M1.40M1.40M1.40M1.22M0.92M0.90M
Change in Working Capital
Change in Receivables 3.16M-2.65M1.11M-0.45M0.86M1.62M12.68M4.30M-2.52M11.21M-2.34M3.77M2.47M1.09M0.71M13.01M
Change in Inventory 2.40M-2.40M0.06M2.21M-0.39M-0.20M1.06M-0.07M0.72M2.88M2.23M4.48M0.77M0.03M
Change in Account Payables 1.91M-1.78M0.35M-0.71M0.37M0.17M
Change in Accured Expenses -0.58M-1.00M1.84M1.81M0.26M1.03M9.43M0.57M5.95M-0.62M3.51M3.76M3.04M11.79M-10.98M1.71M
Change in Taxes 3.90M-2.27M
Other Working Capital Changes 197.43M-26.79M-26.79M-26.79M-1.26M-30.57M2.56M6.16M-3.65M4.26M2.76M-4.07M1.25M6.14M-8.52M6.82M
Investing Activities
Capital Expenditures 0.28M2.02M0.18M0.77M2.53M1.41M1.66M0.37M1.02M1.79M0.55M0.68M0.38M0.49M
Sales of Property, Plant and Equipment 0.07M
Change in Intangibles 12.00M8.00M25.00M
Change in Acquisitions & Divestments 18.50M46.75M226.17M106.14M31.50M80.88M168.04M156.79M139.57M198.10M327.23M306.92M344.32M399.86M601.60M352.06M
Cash from Investing Activities -4.74M-155.62M73.75M45.75M-34.27M-12.04M-26.60M-10.03M-10.23M-109.66M-68.31M-41.50M-76.70M49.92M-12.06M-17.43M
Financing Activities
Other financing activities 2.89M0.03M0.01M1.55M2.85M4.37M7.75M5.25M
Cash from Financing Activities 1.62M3.78M0.03M0.01M49.86M89.73M4.09M7.75M5.25M107.13M6.26M5.63M3.55M0.73M-0.15M
Additional items
Exchange Rate Effect 0.01M0.04M-0.04M-0.00M0.05M-0.09M0.27M0.05M-0.16M
Change in Cash 166.22M-162.74M45.36M0.85M-24.01M-3.86M-10.06M-10.37M-6.92M27.41M-16.10M15.96M-9.02M82.91M0.79M-33.51M
Free Cash Flow 169.34M-10.90M-28.68M-46.93M-39.77M-82.32M9.92M-9.51M-3.65M29.62M44.93M49.98M63.66M31.30M12.42M-16.25M
Net Cash Flow 166.22M-162.74M45.36M0.85M-24.01M-3.86M-10.06M-10.38M-6.96M27.45M-16.10M15.91M-8.93M82.64M0.74M-33.34M